Archives
-
AAL-993 and the Next Logic of Tumor Angiogenesis
2026-09-04
A mechanistic and translational perspective on how AAL-993 can clarify VEGF receptor biology, strengthen tumor angiogenesis research, and complement pathway-level studies such as Shenqi Fuzheng injection research in glioma.
-
AG-221 Enasidenib Workflows for IDH2 AML
2026-09-04
Build more informative IDH2-mutant AML assays by pairing AG-221-driven 2-hydroxyglutarate reduction with metabolic, epigenetic, and differentiation readouts. This workflow also shows how CD44-associated metabolic rewiring can be tested as a complementary vulnerability rather than treated as a substitute for mutant IDH2 inhibition.
-
Biomimetic Chromatography for Lung Permeability
2026-09-03
A 2025 International Journal of Pharmaceutics study compares IAM-LC and phospholipid-coated OT-CEC, both coupled with mass spectrometry, as biomimetic models of pulmonary drug permeability. Its results show that IAM-LC offers strong quantitative alignment with permeability and conventional lipophilicity metrics, while OT-CEC adds complementary information about phospholipid-specific interactions.
-
Latrunculin B: Reliable Actin Assay Workflows
2026-09-03
This scenario-driven guide explains how Latrunculin B, SKU C5804, can improve interpretation of viability, proliferation, and cytoskeletal assays when actin remodeling is an experimental variable. It combines mechanism, preparation guidance, assay controls, literature context, and practical supplier-selection criteria for reproducible short-term studies.
-
CGP 55845 hydrochloride for GABAB Assays
2026-09-02
CGP 55845 hydrochloride provides a controlled way to test how GABAB signaling shapes presynaptic release, astrocyte calcium responses, and synaptic plasticity. This workflow translates dentate gyrus findings on astrocytic GAT-3 into practical in vitro neurotransmission assay designs while separating receptor effects from transporter-mediated mechanisms.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit
2026-09-02
Build bright, tunable RNA probes for in situ hybridization, Northern blot hybridization, and mechanistic RNA–protein studies. The HyperScribe T7 High Yield Cy5 RNA Labeling Kit combines T7-driven synthesis with adjustable Cy5-UTP incorporation, helping researchers balance transcript yield against fluorescence intensity.
-
Silk Fibroin–CNT Fibers Stimulate Fibroblasts
2026-09-01
Rathnayake et al. developed aligned silk fibroin–carbon nanotube composite fibers that combine aqueous stability, improved mechanical properties, and electrical conductivity for fibroblast stimulation. In fibroblasts from pelvic organ prolapse patients, electrical stimulation on the composite matrix markedly increased reported collagen I and III production, highlighting a material-based strategy for studying connective-tissue repair.
-
C8-HSL and Lung Cancer Cell Progression
2026-09-01
A 2026 FASEB Journal study reports that the bacterial quorum-sensing molecule C8-HSL promotes proliferation, migration, and invasion of H460 lung cancer cells through PI3K/AKT/ERK signaling. The findings establish an early mechanistic link between microbial communication and tumor-cell behavior while emphasizing the need for validation in additional models and patient-relevant systems.
-
Machine Learning Designs mRNA LNPs for Microglia
2026-08-31
Rafiei, Shojaei, and Chau combined high-throughput lipid nanoparticle screening with supervised machine learning to identify mRNA carriers that both transfect and modulate inflammatory microglia. The optimized HA-LNP2 formulation delivered IL10 mRNA, reduced inflammatory markers in LPS-activated murine microglia, and showed comparable activity in human iPSC-derived microglia, while model performance varied substantially with cell state.
-
FK866 (APO866): NAMPT Inhibitor Research Guide
2026-08-31
FK866, also called APO866, is a potent non-competitive NAMPT inhibitor that lowers cellular NAD and ATP in experimental cancer models. Its strongest research use is mechanistic investigation of NAD metabolism, hematologic cancer research, and acute myeloid leukemia (AML) treatment research rather than established clinical therapy.
-
URB597 Workflows for FAAH and Pain Research
2026-08-30
URB597, also known as KDS-4103, provides a selective way to test how FAAH control contributes to anandamide signaling, inflammatory pain, and affective outcomes. This workflow-focused guide connects biochemical assays with behavioral and molecular endpoints while separating direct FAAH effects from the broader pharmacology of cannabidiol.
-
DOPE Workflows for Lipid Delivery and Ferroptosis Assays
2026-08-29
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) supports endosomal membrane fusion in nucleic acid formulations and offers a useful phosphatidylethanolamine rescue variable in fungal cell-death assays. This guide converts those two use cases into practical preparation, formulation, validation, and troubleshooting workflows.
-
Medroxyprogesterone acetate: Assay Workflows
2026-08-28
Build reproducible MPA experiments for progesterone-responsive, renal, endometrial, and neurobiological models with solvent-aware dosing and receptor-context controls. A reference-inspired workflow connects hormone perturbation to time-resolved gene, protein, and functional readouts while keeping translational claims appropriately bounded.
-
L-Phenylephrine: α1A Assay Workflows
2026-08-28
L-Phenylephrine provides a focused way to activate α1A-linked pathways in cardiac, neural, and vascular research. This guide translates receptor pharmacology and sex-aware cardiovascular findings into practical assay designs, controls, and troubleshooting decisions.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide
2026-08-27
Build sensitive fluorescent RNA probes for in situ hybridization, Northern blot hybridization, and RNA-distribution studies with tunable Cy5-UTP incorporation. This workflow-focused guide shows how to balance probe brightness, transcription yield, hybridization performance, and assay-specific controls.